ClinConnect ClinConnect Logo
Search / Trial NCT03192267

Early Rheumatoid Arthritis Lung Disease Study

Launched by UNIVERSITY OF NEBRASKA · Jun 16, 2017

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Newly Diagnosed Rheumatoid Arthritis Lung Disease

ClinConnect Summary

The Early Rheumatoid Arthritis Lung Disease Study is looking into how lung disease affects patients who have recently been diagnosed with rheumatoid arthritis (RA). This study is important because about half of people with RA can also have problems with their lungs. Researchers want to understand how common lung issues are in these early RA patients and how they can be identified using surveys, imaging tests, and blood samples. They are also hoping to discover new markers that could help predict lung disease in RA patients.

To participate in this study, you need to be between 19 and 90 years old and have been diagnosed with RA by a specialist within the last two years. Unfortunately, if you are pregnant or have a different kind of inflammatory arthritis that doesn’t fit the RA criteria, you won’t be eligible. If you join the study, you can expect to answer questions about your health, undergo lung function tests, and have imaging done to evaluate your lungs. This research could help improve understanding and treatment of lung disease in individuals with rheumatoid arthritis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 19-90 years of age
  • Able to give informed consent
  • Diagnosis of RA by a Rheumatologist using 2010 American College of Rheumatology (ACR) criteria within the past 2 years
  • Exclusion Criteria:
  • Inflammatory arthritis that does not meet 2010 American College of Rheumatology (ACR) criteria for rheumatoid arthritis (RA)
  • Pregnant

About University Of Nebraska

The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.

Locations

Omaha, Nebraska, United States

Omaha, Nebraska, United States

Patients applied

0 patients applied

Trial Officials

Tina D Mahajan, MD

Study Chair

University of Nebraska

Bryant R England, MD

Principal Investigator

University of Nebraska

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials